Bioskin Tech Laboratories

Also known as: Davao Bioskin Tech Laboratories, Inc. (legal name) · Davao Bioskin Tech Laboratories Inc. · Bioskin Tech Laboratories · Bioskin Tech Laboratories, Inc. · Bioskin (parent manufacturer)

Business

Definition

Bioskin Tech Laboratories, Inc. (legally Davao Bioskin Tech Laboratories, Inc.) is a privately held Philippine skincare and cosmetics contract manufacturer headquartered in Ecoland Subdivision, Matina, Davao City, with a production facility in Sta. Cruz, Davao del Sur. Founded in April 2002 as a subsidiary and incorporated as an independent company in January 2005, the firm operates a dual business model: it manufactures its own consumer skincare brand Bioskin, and provides private-label / contract-manufacturing services to external entrepreneurs, dermatologists, direct-selling companies, and trading houses. The company is owned and operated by spouses Maria Victoria C. Evangelista (Chief Executive Officer) and Gerardo C. Evangelista (Chief Operating Officer). The company tagline is “Helping entrepreneurs launch their skincare line since 2004.” (Listcompany — Davao Bioskin Tech Laboratories Inc., Edge Davao — Sabah MOU, Edge Davao — UAE distribution)

Identities

Source Type	Identity
Wikipedia	N/A
Wikidata	N/A
DBpedia	N/A
ProductOntology	N/A
Wiktionary	N/A
Library of Congress Subject Headings (LCSH)	Contract manufacturing — Philippines / Cosmetics industry — Philippines
MeSH	N/A
NCBI Taxonomy	N/A
AGROVOC	Coconut products — Philippines
Google Scholar	“Davao Bioskin Tech Laboratories”
ConceptNet	N/A
OpenCyc	N/A

Also Known As

Davao Bioskin Tech Laboratories, Inc. (legal name)
Davao Bioskin Tech Laboratories Inc.
Bioskin Tech Laboratories
Bioskin Tech Laboratories, Inc.
Bioskin (parent manufacturer)

Examples and Analogies

Contract-manufacturing “foundry” model: Bioskin Tech Laboratories is to Philippine skincare what Foxconn or Flex are to consumer electronics — a behind-the-scenes manufacturer that produces finished goods for multiple brands. Clients bring the brand and budget; Bioskin brings the formulation chemists, raw materials, primary packaging (bottles, jars, canisters), and regulatory documentation. This is the structural difference between Bioskin and purely consumer-facing skincare brands like Human Heart Nature or Celeteque.
Mindanao-based export manufacturer: Bioskin’s Sta. Cruz production facility and coconut supply chain position it alongside other Davao del Sur agribusiness exporters such as Franklin Baker Company (a global coconut processor with operations in Sta. Cruz) and San Miguel Brewery‘s Davao facility.
Verified corporate data points:
Headquarters: Lot 11, Block 4, Maya Street, Phase 2 Ecoland Subdivision, Matina, Davao City, 8000. (Service Finder PH — Bioskin Tech Laboratories, Inc.)
Historical address: Door 7, Building 2, Regina Commercial Complex, CM Recto Avenue, Davao City. (Listcompany — Davao Bioskin Tech Laboratories Inc.)
Production facility: Sta. Cruz, Davao del Sur (coconut sourcing region at the foot of Mt. Apo).
Phone: +63 82 305 4631 (landline); +63 905 323 7628 (mobile).
Email: [email protected]
Business hours: Monday–Saturday, 9:00 AM – 10:00 PM.

Usage Scenarios

1. Private-Label / Contract Manufacturing (B2B)

Entrepreneurs, licensed dermatologists, direct-selling companies, and consumer trading houses contract Bioskin Tech Laboratories to formulate and manufacture custom skincare lines under the buyer’s brand. Bioskin supplies the formulation, raw materials, primary packaging, and regulatory documentation; the buyer supplies the brand identity and budget. The company’s own description claims clients “range from budding entrepreneurs, professional Dermatologist, Direct Selling Companies and Consumer Trading Companies Local & Export.” (Listcompany — Davao Bioskin Tech Laboratories Inc.)

2. International Distribution via DTI-Supported Business Matching

Overseas distributors sign exclusive regional contracts originating at trade expos supported by the Department of Trade and Industry – Region XI (DTI-Davao), the Mindanao Development Authority (MinDA), and the Department of Tourism Region XI. The signature deal-flow event was the Sabah International Expo 2023 in Kota Kinabalu (September 2023), which produced Bioskin’s first two verified export contracts in November–December 2023. (Edge Davao — Sabah MOU)

3. Local MSME and IP Sourcing

Through CEO Maria Victoria Evangelista’s parallel role as President of the Sta. Cruz Chamber of Commerce and Industry Inc. (since 2024), the company participates in MSME development programs — sourcing coconut, coffee, and banana inputs from local farmers and Indigenous Peoples communities such as the Bagobo-Tagabawa tribe’s Tibolo Farm Workers Association (TIFWA) in Barangay Tibolo, Sta. Cruz. (Inquirer — Davao del Sur business leaders, Edge Davao — Sta. Cruz Chamber)

4. Purchase-Linked Charitable Contributions

A portion of every product sale (Bioskin-branded and contract-manufactured) is donated to Field of Dreams, an orphanage in Biao Guianga, Tugbok, Davao City — disclosed publicly by the CEO in Edge Davao interviews. (Edge Davao — UAE distribution)

Strategies

Dual revenue stream: combine consumer-brand revenue (Bioskin-branded SKUs via bioskin.ph and Shopee) with higher-margin B2B contract manufacturing — smoothing demand volatility typical of pure consumer brands.
Geographic anchor in coconut supply chain: locate the production facility in Sta. Cruz, Davao del Sur — a major coconut-producing municipality — to secure upstream VCO supply and reduce raw-material logistics costs.
Regulatory positioning: maintain the company’s claimed regulatory stack (FDA Certificate of Product Notification, ISO 22716 Cosmetic GMP, Halal certification) as a competitive moat when bidding for B2B contracts from dermatologists and direct-selling brands who require documented compliance.
DTI-supported export channel: route international expansion through DTI-Davao, MinDA, and DOT-11 business-matching programs rather than solo export development — leveraging government trade-mission infrastructure.

Security and Safety Measures

All cosmetic products manufactured or imported into the Philippines require a Certificate of Product Notification (CPN) from the FDA Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research, under Republic Act No. 9711 (FDA Act of 2009) and AO No. 2016-0003 (ASEAN Cosmetic Directive adoption).
The manufacturing establishment itself requires an FDA License to Operate (LTO) as a cosmetic manufacturer — separate from per-product CPNs.
Claimed voluntary certifications (not publicly verifiable as of July 2026): ISO 22716 Cosmetic Good Manufacturing Practice, and Halal certification from an unnamed certifying body. Verification of these claims requires direct request to the company.
For B2B clients: the company’s regulatory documentation package (CPN per product, LTO, ISO 22716 certificate) should be requested and independently verified before contracting for private-label manufacturing.
Contract-manufactured products sold under client brands inherit Bioskin’s manufacturing-side compliance posture but require the client brand to secure its own CPN per FDA rules.

Historical Context

Davao Bioskin Tech Laboratories Inc. began operations in Davao City in April 2002 as a subsidiary company and was reorganized as an independent company in January 2005 under the ownership of Maria Victoria C. Evangelista and Gerardo C. Evangelista — per the company’s own self-published profile on business directories. The company is duly licensed by the Food and Drug Administration (formerly the Bureau of Food and Drugs / BFAD), the Department of Trade and Industry (DTI), and the Securities and Exchange Commission (SEC). (Listcompany — Davao Bioskin Tech Laboratories Inc.)

Public sources cite multiple, partially conflicting founding years — 2002 (subsidiary start), 2004 (Tech Lab Facebook tagline “since 2004”), 2005 (independent incorporation), and 2006 (December 2023 Edge Davao article quoting Maria Victoria). The most defensible primary-source dating is April 2002 (operational start) and January 2005 (independence), with later marketing rounding variously. (Edge Davao — UAE distribution, Facebook — Bioskin Tech Laboratories, Inc.)

Bioskin’s strategic pivot toward coconut-based formulations tracks the rise of the Philippine VCO industry, which received regulatory backing through DP No. 76-A s. 2010 (Philippine National Standards for Virgin Coconut Oil) and export promotion via the Philippine Coconut Authority (under DTI).

The company’s verified international expansion milestones:

November 22, 2023 — Memorandum of Understanding with Malaysian investor K.Y. Chung (represented by Filipino business partner Wewin Aldor) for exclusive distribution of Bioskin’s coconut-product lines in Sabah, Malaysia — 5,000 sets per variant, one-year contract. Signed in Davao City. (Edge Davao — Sabah MOU)
December 28, 2023 — Exclusive retail agreement with UAE-based entrepreneur Corazon Carlos for the “Oli” product line in the United Arab Emirates, with 1,000 units initially shipped to seed the market. Signed at the Bioskin office in Ecoland, Davao City. (Edge Davao — UAE distribution)
August 2025 — Inquirer Mindanao reports Bioskin products exporting to the United States and Canada, creating demand for Sta. Cruz raw materials and benefiting upstream IP-led producers. (Inquirer — Davao del Sur business leaders)

The company has been profiled in the Dun & Bradstone business directory under the entry “Davao Bioskin Tech Laboratories, Inc.” (Davao City, Davao del Sur). (D&B — Davao Bioskin Tech Laboratories)

Challenges and Controversies

Founding-Date Inconsistency

Public sources cite at least four different founding years — 2002, 2004, 2005, and 2006. This is a transparency limitation typical of founder-led Philippine SMEs without a public SEC historical filing; consumers, journalists, and B2B counterparties cannot easily resolve the discrepancy without primary SEC records.

Self-Reported Certifications Without Public Numbers

The company’s public listings claim “FDA Approved, ISO Certified, Halal Certified.” Specific CPN numbers, ISO certificate numbers, Halal certifying body names, and certificate expiration dates are not publicly listed on the company’s storefront or in third-party business directories as of July 2026. B2B clients and journalists should request and independently verify these documents before relying on them. (Service Finder PH — Bioskin Tech Laboratories, Inc.)

Limited Public Disclosure of Corporate Financials

Davao Bioskin Tech Laboratories, Inc. is a privately held company; revenue, profit, market share, and headcount are not publicly disclosed. Third-party business directories list employee counts ranging from 14 (RocketReach) to 51–100 (Listcompany); such third-party estimates should be treated as approximations only. The company does not publish audited financial statements.

Ownership / Officer Title Inconsistency in Press

A December 2023 Edge Davao article body textually referred to Maria Victoria Evangelista as “chief operating officer” in one paragraph while the accompanying photo caption (same article) identified her as CEO. Other sources — including the photo caption of the same article, the parallel Sabah-distribution article one month earlier, and her 2025 Sta. Cruz Chamber role — consistently identify her as CEO. The “COO” reference appears to be a news-article error; Gerardo C. Evangelista is consistently named COO.